Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

The endothelin receptor type A is a downstream target of Hoxa9 and Meis1 in acute myeloid leukemia.

Arabanian LS, Johansson P, Staffas A, Nilsson T, Rouhi A, Fogelstrand L, Palmqvist L.

Leuk Res. 2018 Dec;75:61-68. doi: 10.1016/j.leukres.2018.10.005. Epub 2018 Oct 13.

PMID:
30384975
2.

Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemia.

Schneider E, Staffas A, Röhner L, Malmberg ED, Ashouri A, Krowiorz K, Pochert N, Miller C, Wei SY, Arabanian L, Buske C, Döhner H, Bullinger L, Fogelstrand L, Heuser M, Döhner K, Xiang P, Ruschmann J, Petriv OI, Heravi-Moussavi A, Hansen CL, Hirst M, Humphries RK, Rouhi A, Palmqvist L, Kuchenbauer F.

Haematologica. 2018 Feb;103(2):246-255. doi: 10.3324/haematol.2017.177485. Epub 2017 Dec 7.

3.

Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice.

Staffas A, Arabanian LS, Wei SY, Jansson A, Ståhlman S, Johansson P, Fogelstrand L, Cammenga J, Kuchenbauer F, Palmqvist L.

Oncogene. 2017 Mar;36(11):1516-1524. doi: 10.1038/onc.2016.318. Epub 2016 Sep 12.

PMID:
27617578
4.

Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expression.

Kopparapu PK, Bhoi S, Mansouri L, Arabanian LS, Plevova K, Pospisilova S, Wasik AM, Croci GA, Sander B, Paulli M, Rosenquist R, Kanduri M.

Epigenetics. 2016 May 3;11(5):335-43. doi: 10.1080/15592294.2016.1164375. Epub 2016 Apr 6.

5.

Breast carcinoma cells modulate the chemoattractive activity of human bone marrow-derived mesenchymal stromal cells by interfering with CXCL12.

Wobus M, List C, Dittrich T, Dhawan A, Duryagina R, Arabanian LS, Kast K, Wimberger P, Stiehler M, Hofbauer LC, Jakob F, Ehninger G, Anastassiadis K, Bornhäuser M.

Int J Cancer. 2015 Jan 1;136(1):44-54. doi: 10.1002/ijc.28960. Epub 2014 May 20.

6.

MicroRNA-23a mediates post-transcriptional regulation of CXCL12 in bone marrow stromal cells.

Arabanian LS, Fierro FA, Stölzel F, Heder C, Poitz DM, Strasser RH, Wobus M, Borhäuser M, Ferrer RA, Platzbecker U, Schieker M, Docheva D, Ehninger G, Illmer T.

Haematologica. 2014 Jun;99(6):997-1005. doi: 10.3324/haematol.2013.097675. Epub 2014 Feb 28.

7.

MiR-134-mediated β1 integrin expression and function in mesenchymal stem cells.

Poitz DM, Stölzel F, Arabanian L, Friedrichs J, Docheva D, Schieker M, Fierro FA, Platzbecker U, Ordemann R, Werner C, Bornhäuser M, Strasser RH, Ehninger G, Illmer T.

Biochim Biophys Acta. 2013 Dec;1833(12):3396-3404. doi: 10.1016/j.bbamcr.2013.10.003. Epub 2013 Oct 15.

8.

Regulation of fas/fas ligand-mediated apoptosis by nuclear factor of activated T cells in megakaryocytes.

Arabanian LS, Kujawski S, Habermann I, Ehninger G, Kiani A.

Br J Haematol. 2012 Feb;156(4):523-34. doi: 10.1111/j.1365-2141.2011.08970.x. Epub 2011 Dec 15.

PMID:
22171718
9.

Osteomyelosclerosis, anemia and extramedullary hematopoiesis in mice lacking the transcription factor NFATc2.

Bauer W, Rauner M, Haase M, Kujawski S, Arabanian LS, Habermann I, Hofbauer LC, Ehninger G, Kiani A.

Haematologica. 2011 Nov;96(11):1580-8. doi: 10.3324/haematol.2011.042515. Epub 2011 Jul 12.

Supplemental Content

Loading ...
Support Center